000 | 01831 a2200505 4500 | ||
---|---|---|---|
005 | 20250517012253.0 | ||
264 | 0 | _c20150313 | |
008 | 201503s 0 0 eng d | ||
022 | _a1541-8243 | ||
024 | 7 |
_a10.14423/SMJ.0000000000000217 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aShujaat, Adil | |
245 | 0 | 0 |
_aUse of pulmonary arterial hypertension-specific therapy in non-WHO group I pulmonary hypertension. _h[electronic resource] |
260 |
_bSouthern medical journal _cJan 2015 |
||
300 |
_a51-7 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAntihypertensive Agents _xtherapeutic use |
650 | 0 | 4 | _aCohort Studies |
650 | 0 | 4 |
_aEndothelin Receptor Antagonists _xtherapeutic use |
650 | 0 | 4 |
_aEpoprostenol _xanalogs & derivatives |
650 | 0 | 4 | _aExercise Test |
650 | 0 | 4 |
_aExercise Tolerance _xphysiology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypertension, Pulmonary _xdrug therapy |
650 | 0 | 4 |
_aLung Diseases, Interstitial _xcomplications |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPhosphodiesterase 5 Inhibitors _xtherapeutic use |
650 | 0 | 4 |
_aProstaglandins _xtherapeutic use |
650 | 0 | 4 |
_aPulmonary Disease, Chronic Obstructive _xcomplications |
650 | 0 | 4 | _aRespiratory Function Tests |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 |
_aSarcoidosis _xcomplications |
650 | 0 | 4 | _aSeverity of Illness Index |
650 | 0 | 4 |
_aSleep Apnea, Obstructive _xcomplications |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 | _aWorld Health Organization |
700 | 1 | _aBellardini, Jason | |
700 | 1 | _aCury, James D | |
700 | 1 | _aBajwa, Abubakr A | |
773 | 0 |
_tSouthern medical journal _gvol. 108 _gno. 1 _gp. 51-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.14423/SMJ.0000000000000217 _zAvailable from publisher's website |
999 |
_c24526421 _d24526421 |